{"disease":{"id":"osteosarcoma","name":"osteosarcoma"},"drugs":{"marketed":[{"drug_id":"adriacin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"adriacin","company_name":"Chipscreen Biosciences, Ltd.","drug_phase":"phase_1","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxydaunorubicin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxydaunorubicin","company_name":"University of Colorado, Denver","drug_phase":"phase_2","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mifamurtide","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepact","generic_name":"MIFAMURTIDE","company_name":"Takeda France SAS","drug_phase":"marketed","molecular_target":"Nucleotide-binding oligomerization domain-containing protein 2","drug_class":"mifamurtide","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"liposomal-doxorubicin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Liposomal Doxorubicin","generic_name":"liposomal-doxorubicin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase","drug_class":"doxorubicin","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"doxorubicin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Doxorubicin Hydrochloride","generic_name":"doxorubicin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Aurora kinase A","drug_class":"Anthracycline Topoisomerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division."},{"drug_id":"methotrexate","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trexall","generic_name":"methotrexate","company_name":"Generic (originally Lederle Laboratories)","drug_phase":"marketed","molecular_target":"Canalicular multispecific organic anion transporter 1, High mobility group protein B1, Multidrug resistance-associated protein 4","drug_class":"Antifolate, DMARD","quality_score":55,"revenue":null,"mechanism":"Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune)."},{"drug_id":"methotrexat","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methotrexat","company_name":"Biocad","drug_phase":"marketed","molecular_target":"Canalicular multispecific organic anion transporter 1, High mobility group protein B1, Multidrug resistance-associated protein 4","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxydaunomycin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxydaunomycin","company_name":"Weill Medical College of Cornell University","drug_phase":"phase_2","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adriamycin","indication_name":"Osteosarcoma of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adriamycin","company_name":"Johann Wolfgang Goethe University Hospital","drug_phase":"marketed","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00026780","title":"Eligibility Screening for a NCI Pediatric Oncology Branch Research Study","phase":"","overall_status":"COMPLETED","enrollment_count":1720,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03155620","title":"Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1377,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00134030","title":"Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1334,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT05691478","title":"A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":1122,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00899275","title":"Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma","phase":"","overall_status":"COMPLETED","enrollment_count":957,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04735289","title":"Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma","phase":"","overall_status":"UNKNOWN","enrollment_count":810,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT05194605","title":"Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07215728","title":"Machine Learning Applied to EHRs Data of Patients With Sarcoma","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT05093101","title":"The Prognostic Value of Serum Biomarkers in Osteosarcoma","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT03496402","title":"Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT00346164","title":"Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":588,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT00840047","title":"Methionine PET/CT Studies In Patients With Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":503,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05328258","title":"Use of GnRHa During Chemotherapy for Fertility Protection","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Kenny Rodriguez-Wallberg","has_results":false},{"nct_id":"NCT04671693","title":"A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT06699576","title":"ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":448,"lead_sponsor_name":"Hansoh BioMedical R&D Company","has_results":false},{"nct_id":"NCT01790152","title":"Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT07321912","title":"Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":406,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT03932058","title":"Proteomics Research of Osteosarcoma","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03225872","title":"Biology of Osteosarcoma (BOOST) Registry and Biobank","phase":"","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04359550","title":"Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant Chemotherapy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":362,"lead_sponsor_name":"Lee's Pharmaceutical Limited","has_results":false},{"nct_id":"NCT06162962","title":"Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient","phase":"","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"Changye Zou","has_results":false},{"nct_id":"NCT06068075","title":"Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD","phase":"NA","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04132895","title":"ICONIC: Improving Outcomes Through Collaboration in OsteosarComa","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04644913","title":"Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT03442465","title":"Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03298971","title":"The Impact of Cancer on the Physical and Psychosocial Well-being Among Childhood Osteosarcoma Survivors","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT01459484","title":"ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Italian Sarcoma Group","has_results":false},{"nct_id":"NCT03206450","title":"Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors","phase":"","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT03768076","title":"an Istitution Experience on Parosteal OsTeosarcoma","phase":"","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT00617890","title":"A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":219,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00898755","title":"Collecting and Storing Tissue From Young Patients With Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT05942456","title":"Soluble B7-H3 as a Biomarker for Osteosarcoma","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03911245","title":"Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival","phase":"","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT02162732","title":"Molecular-Guided Therapy for Childhood Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Giselle Sholler","has_results":true},{"nct_id":"NCT03362086","title":"The Osteosarcoma Biobank in Peking University People's Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT02357810","title":"Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT05830123","title":"ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Hansoh BioMedical R&D Company","has_results":false},{"nct_id":"NCT04055220","title":"Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas","phase":"NA","overall_status":"RECRUITING","enrollment_count":168,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT03063983","title":"Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":158,"lead_sponsor_name":"Grupo de Apoio ao Adolescente e a Crianca com Cancer","has_results":false},{"nct_id":"NCT06017518","title":"An Observational Study of Local Relapse After High Grade Osteosarcoma","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT06387485","title":"A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ricoh USA, Inc.","has_results":false},{"nct_id":"NCT04851119","title":"Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":147,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT07516353","title":"my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":143,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT02304458","title":"Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02180867","title":"Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04546243","title":"Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT01190943","title":"DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04890067","title":"Observational Study in Localized Osteosarcoma","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Italian Sarcoma Group","has_results":false},{"nct_id":"NCT01353625","title":"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Celgene","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}